Literature DB >> 17661328

A novel extracellular protease with fibrinolytic activity from the culture supernatant of Cordyceps sinensis: purification and characterization.

Hua-ping Li1, Zheng Hu, Jiang-lan Yuan, Han-dong Fan, Wei Chen, Shi-jia Wang, Shan-shan Zheng, Zhong-liang Zheng, Guo-lin Zou.   

Abstract

A novel serine protease with fibrinolytic activity named CSP was purified from the culture supernatant of the fungus Cordyceps sinensis, a kind of Chinese herbal medicine. Analysis of the purified enzyme by SDS-PAGE indicated that CSP was a single polypeptide chain with an apparent molecular weight of 31 kDa, and N-terminal sequencing revealed that the first ten amino acid residues of the enzyme were Ala-Leu-Ala-Thr-Gln-His-Gly-Ala-Pro-Trp-. When casein was used as a substrate, the proteolytic activity of CSP reached its maximum at pH 7.0 and 40 degrees C. The effect of chemical agents on the enzyme activity indicated that CSP is a serine protease with a free cysteine residue near the active site. It hydrolysed fibrinogen, fibrin and casein with a high efficiency, while hydrolysing bovine serum albumin (BSA) and human serum albumin (HSA) to a lesser extent. CSP was found to be a plasmin-like protease, but not a plasminogen activator, and it preferentially cleaved the A alpha chain of fibrinogen and the alpha-chain of fibrin. Therefore, the extracellular protein CSP may represent a potential new therapeutic agent for the treatment of thrombosis. Copyright (c) 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17661328     DOI: 10.1002/ptr.2246

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  8 in total

1.  Purification and partial characterization of a chymotrypsin-like serine fibrinolytic enzyme from Bacillus amyloliquefaciens FCF-11 using corn husk as a novel substrate.

Authors:  Essam Kotb
Journal:  World J Microbiol Biotechnol       Date:  2014-03-08       Impact factor: 3.312

Review 2.  Phytochemicals in Ischemic Stroke.

Authors:  Joonki Kim; David Yang-Wei Fann; Raymond Chee Seong Seet; Dong-Gyu Jo; Mark P Mattson; Thiruma V Arumugam
Journal:  Neuromolecular Med       Date:  2016-05-18       Impact factor: 3.843

Review 3.  Fibrinolytic Enzymes for Thrombolytic Therapy.

Authors:  Swaroop S Kumar; Abdulhameed Sabu
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

Review 4.  Natural Products for Antithrombosis.

Authors:  Cen Chen; Feng-Qing Yang; Qian Zhang; Feng-Qin Wang; Yuan-Jia Hu; Zhi-Ning Xia
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-17       Impact factor: 2.629

Review 5.  The Chemical Constituents and Pharmacological Actions of Cordyceps sinensis.

Authors:  Yi Liu; Jihui Wang; Wei Wang; Hanyue Zhang; Xuelan Zhang; Chunchao Han
Journal:  Evid Based Complement Alternat Med       Date:  2015-04-16       Impact factor: 2.629

Review 6.  A Systematic Review of the Mysterious Caterpillar Fungus Ophiocordyceps sinensis in Dong-ChongXiaCao ( Dōng Chóng Xià Cǎo) and Related Bioactive Ingredients.

Authors:  Hui-Chen Lo; Chienyan Hsieh; Fang-Yi Lin; Tai-Hao Hsu
Journal:  J Tradit Complement Med       Date:  2013-01

7.  Evaluation of essential oil obtained from Mentha×piperita L. against multidrug-resistant strains.

Authors:  Delia Muntean; Monica Licker; Ersilia Alexa; Iuliana Popescu; Calin Jianu; Valentina Buda; Cristina Adriana Dehelean; Roxana Ghiulai; Florin Horhat; Delia Horhat; Corina Danciu
Journal:  Infect Drug Resist       Date:  2019-09-13       Impact factor: 4.003

Review 8.  Thrombolytic Enzymes of Microbial Origin: A Review.

Authors:  Deepti Diwan; Zeba Usmani; Minaxi Sharma; James W Nelson; Vijay Kumar Thakur; Graham Christie; Gustavo Molina; Vijai Kumar Gupta
Journal:  Int J Mol Sci       Date:  2021-09-28       Impact factor: 6.208

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.